Search Results - "van Hateren, Hans"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    A cellular and molecular model of response kinetics and adaptation in primate cones and horizontal cells by van Hateren, Hans

    Published in Journal of vision (Charlottesville, Va.) (15-04-2005)
    “…A model for the sensitivity regulation in the primate outer retina is developed and validated using horizontal cell measurements from the literature. The main…”
    Get full text
    Journal Article
  3. 3

    A model of spatiotemporal signal processing by primate cones and horizontal cells by van Hateren, J H

    Published in Journal of vision (Charlottesville, Va.) (19-02-2007)
    “…A model of spatiotemporal signal processing by the cone-horizontal cell circuit in the primate outer retina is developed and validated using measurements on…”
    Get full text
    Journal Article
  4. 4
  5. 5

    SGLT-2 inhibitors: diabetes treatment by glycosuria; literature review on the effect of dapagliflozin by Kleefstra, Nanne, Drion, Iefke, van Hateren, K J J Hans, Holleman, Frits, Goudswaard, A N Lex, Bilo, Henk J G

    “…To describe the efficacy and safety of dapagliflozin, the first sodium-glucose co-transporter-2 (SGLT-2) inhibitor for the treatment of diabetes mellitus type…”
    Get more information
    Journal Article
  6. 6

    Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based by Spaans, E A J M Angelien, Kleefstra, Nanne, van Hateren, K J J Hans, Aanstoot, Henk-Jan, Bilo, Henk J G, Brand, Paul L P

    “…Adolescents with type 1 diabetes mellitus (DM1) often have problems in achieving optimal glycaemic control. We investigated whether there is evidence of the…”
    Get more information
    Journal Article
  7. 7

    New blood glucose-lowering drugs in type 2 diabetes: a review of the literature by Kleefstra, Nanne, van Hateren, K J J Hans, Houweling, S T Bas, Verhoeven, Simon, Kooy, Adriaan, Goudswaard, A N Lex, Bilo, Henk J G

    “…To describe the efficacy and safety of the glucagon-like peptide 1 (GLP-1) analogues exenatide and liraglutide, and the dipeptidyl peptidase-4 (DPP-4)…”
    Get more information
    Journal Article